ATLANTA, Sept. 25, 2023 /PRNewswire/ -- Mikart, LLC, a contract development and manufacturing organization (CDMO) that specializes in a variety of services from development project work to commercial manufacturing for solid and liquid oral dosage forms, is pleased to announce its recent acquisition of the state-of-the-art Flexpack NF-150 Horizontal Sachet-Packaging Machine.

亚特兰大，2023年9月25日/PRNewswire/-Mikart，LLC，一家合同开发和制造组织（CDMO），专门从事从开发项目工作到固体和液体口服剂型商业制造的各种服务，很高兴宣布其最近收购最先进的Flexpack NF-150横袋包装机。

This strategic investment marks a significant milestone in Mikart's, commitment to enhancing its production capabilities and delivering high-quality pharmaceutical products. .

这项战略投资标志着Mikart的一个重要里程碑，致力于提高其生产能力和提供高质量的药品。 .

Continue Reading

继续阅读

FlexPack NF-150 Horizontal Sachet- Packaging machine for Clinical and Commercial Manufacturing Packaging

FlexPack NF-150水平袋-用于临床和商业制造包装的包装机

The acquisition of the Flexpack NF-150 exemplifies Mikart's unwavering dedication to listening and responding to our customers. It builds on Mikart's already robust packaging footprint, which includes blister packaging, pouch/foil strip packs, cartoning and tray packaging, unit dose cups, and bottle filling.

收购Flexpack NF-150体现了Mikart坚定的奉献精神，倾听和回应我们的客户。它建立在Mikart已经坚固的包装基础上，其中包括泡罩包装，袋/箔条包装，纸箱和托盘包装，单位剂量杯和瓶子填充。

Mikart's packaging lines are fully serialized including aggregation from the unit bottle to pallet quantities.  This new investment aims to increase client demand for clinical and commercial scale sachet packaging capabilities and cover a wide range of product types and packaging configurations.  .

米卡特的包装线完全序列化，包括从单位瓶到托盘数量的聚合。这项新投资旨在增加客户对临床和商业规模小袋包装能力的需求，并涵盖广泛的产品类型和包装配置。  .

'We believe that our investment in the Flexpack NF-150 marks a pivotal moment for Mikart's capabilities expansion plan. The sachet packaging capabilities was done as a result of customer demand and will enhance our packaging capabilities, allowing us to deliver a wider packaging offering for the pharmaceutical products we manufacture,' said Micheal Kallelis, Chief Executive Officer at Mikart. .

“我们相信，我们对Flexpack NF-150的投资标志着Mikart能力扩展计划的关键时刻。Mikart首席执行官Micheal Kallelis说，小袋包装功能是由于客户需求而完成的，并将增强我们的包装能力，使我们能够为我们制造的药品提供更广泛的包装。 .

'We are excited to add the Flexpack NF 150 to our packaging capabilities,' said Nazar Elkarim, VP of Product Development Services at Mikart. 'This machine will allow us to produce a wider variety of pouches, including single or twin sachets, and different shapes. This will help us to better meet the needs of our customers as our business continues to grow.'About Mikart Mikart, LLC is a privately-owned contract development and manufacturing organization founded in 1975.

“我们很高兴将Flexpack NF 150添加到我们的包装功能中，”Mikart产品开发服务副总裁Nazar Elkarim说这台机器将使我们能够生产各种各样的小袋，包括单袋或双袋，以及不同的形状。随着业务的不断发展，这将帮助我们更好地满足客户的需求关于Mikart Mikart，LLC是一家成立于1975年的私营合同开发和制造组织。

Through various technologies, including combination products, oral solutions, and suspensions, Mikart focuses on small molecules, potent compounds, oral solids, non-sterile liquids, and suspensions. Through a full range of formulation, analytical, and manufacturing services, Mikart provides pharmaceutical companies with a complete and seamless development solution that minimizes the time to market through clinical trials and commercial launches. Follow us on LinkedIn to stay informed: www.linkedin.com/company/mikart-LLC, or for more information, visit us at www.mikart.com Contact information:Michelle HallVP, Marketing Mikart, LLC[email protected] SOURCE Mikart, LLC.

通过各种技术，包括组合产品，口服溶液和悬浮液，Mikart专注于小分子，强效化合物，口服固体，非无菌液体和悬浮液。通过全面的配方，分析和制造服务，Mikart为制药公司提供完整无缝的开发解决方案，通过临床试验和商业发布最大限度地缩短上市时间。按照我们的LinkedIn保持通知：www.LinkedIn.com/company/mikart-LLC，或欲了解更多信息，请访问我们的www.mikart.com联系信息：Michelle HallVP，Marketing mikart，LLC[电子邮件保护]SOURCE mikart，有限责任公司。